Navigation Links
Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
Date:9/29/2008

New VBR is designed to offer a less invasive surgical approach to the

thoracolumbar spine

MARQUETTE, Mich., Sept. 29 /PRNewswire/ -- Pioneer Surgical Technology, Inc. announced today the market release of the Cross-Fuse(TM) Lateral Option System. The Cross-Fuse is Pioneer's latest addition to a comprehensive family of PEEK (poly-ether-ether-ketone) VBRs.

Dr. Richard Nussbaum of the Los Angeles Orthopaedic Institute in Sherman Oaks, California says, "The Cross-Fuse provides surgeons the option of performing a lateral procedure for fusing the spine which is less disrupting to back muscles, ligaments and major vessels in posterior spinal surgery. The use of Cross-Fuse in conjunction with percutaneous fixation results in improved patient outcomes." According to Nussbaum, "By combining an easy to use implant system with a lateral approach procedure, it's likely we'll see reduced Operating Room times." The Cross-Fuse System is designed to restore the biomechanical integrity of the thoracolumbar spine.

"The entire Cross-Fuse system, from implants to instrumentation, is well thought out," according to Dr. Thomas Highland of the Columbia Orthopaedic Group, Columbia, Missouri. Highland states, "The innovative design of the trial spacers and other instruments are very user-friendly, and the PEEK material in the Cross-Fuse implants causes no artifact in MRI or CT imaging."

The Cross-Fuse system is designed to be used with Pioneer's Quantum(R) Spinal Rodding System and the Clarity(TM) Lateral Retractor System.

About Pioneer Surgical Technology

Pioneer Surgical Technology, Inc., headquartered in Marquette, Michigan, is a dynamic medical device firm with a full line of cutting-edge motion preservation devices, either available commercially in Europe or under clinical evaluation in the U.S. Pioneer's signature articulating P3(TM) Technology - Pioneer PEEK-on-PEEK, in its NuBac(TM) disc arthroplasty system
'/>"/>

SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
2. Pioneer(R) Surgical Technology, Inc. Continues to Prove Science Behind PEEK-on-PEEK(TM) Technology for Motion Preservation Devices
3. An analysis of the surgical and perioperative complications in right hepatectomies
4. Surgical technique halts cell loss, Parkinsons researchers find
5. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
6. Older Adults Reluctant to Question Surgical Treatment
7. Study shows that surgical weight loss does not eliminate obstructive sleep apnea
8. Specialty Surgery Center to Partner With Surgical Care Affiliates
9. STAAR Surgical to Present at the Noble Financial Equity Conference
10. Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
11. New Steril-Eze Surgical Case Carts from Eagle MHC Feature Rugged, Easy-Clean Design

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...s,andPressJoinEfforttoEducate ,, MEMPHIS,Tenn....nalBipolarFoundationandtheMedicAlertFoundationrece...ram,whichisnowbeingwidelyacceptedasapreventiveheal...ipolarFoundationreceivedaproclamationofendorsement...ouisianaMitchLandrieu.TheNationalBipolarFoundation...
(Date:11/25/2009)...istically significant survival benefit from adjuva...r (ER)-positive tumors had high levels of phosphor...P), according to a brief communication published o...Cancer Institute . , Approximately 50% of breast...l studies have shown that ER-alpha S118-P is requi...
(Date:11/25/2009)...s simple question has been the focus of intense re...dulates High Blood Pressure in Mice & Men, Does s...on has been the focus of intense research for many...stablished a link between a novel gene, phosducin,... as well as humans. The studies were directed by s...
(Date:11/25/2009)... arthritis, could help newly diagnosed diabetics, ...thDay News) -- A drug commonly used to treat non-H...o shows some promise in helping patients newly dia...mab (Rituxan), helped patients keep producing some... destroyed some of their pancreatic beta cells, wh...
(Date:11/25/2009)...o overlook needed care, study finds , , ...depression can worsen her child,s asthma, U.S. res... 262 black mothers and their children found that c... had more frequent asthma symptoms, while children...s frequent asthma symptoms. , The Johns Hopkins...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
...arry Minnix, President & CEO, American Association...ation of the Medicare Therapy,Caps Exceptions Proc...,from Larry Minnix, President & CEO, American Asso...in having their physical and,occupational therapy ...
... The American Medical,Association (AMA) Foundation...ysician association, recently named several new bo...ers:, -- Jean Howard, Traverse City, MI, Preside...aynard, M.D., Evansville, IN, Secretary, New Mem...
...l sunscreen available at retailers nationwide and ... , ORLANDO, Fla., July 2 Caribbean Solutions,( h...een, Caribbean Sol,SolGuard SPF 25 and Kids Kare 2...ttp://www.newscom.com/cgi-bin/prnh/20080702/LAW520...
... only to childbirth as most common reason for hosp..., July 2 (HealthDay News) -- In 2006, more than 1....opulation of Dallas -- were hospitalized for pneum...mission to hospital, and treating these lung infec...
...Technologies from Los Alamos National Laboratory ... Airplanes, Cars Go On a Nanotechnology ...fics (Pink Sheets: MHTX) announced today that it h...enator,Jeff Bingaman said, "I believe the merger o...
...(July 2, 2008) - Measuring calcium deposits in the...isk in American adults, even when they are elderly...ssue of Journal of the American College of Cardio...l Center (LA BioMed), said previous studies had fo...
Other Medicine News:Health News:AAHSA Statement: Therapy Caps Ration Care 2Health News:Caribbean Sol Biodegradable Sunscreen Gets Strong Safety Rating From Environmental Working Group 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 3Health News:Manhattan Scientifics Acquires Metallicum, Inc. 4Health News:New study finds coronary arterial calcium scans help detect overall death risk in the elderly 2
(Date:11/25/2009)...swire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),a...vering,developingandcommercializingnoveldrugstotre...scalyearendedSeptember30,2009.AtSeptember30,2009Ph...hortterminvestments. ,, PipelineUpdateand2009H..., InlateNovember2009,anindependentDataMonitorin...
(Date:11/25/2009)...,Nov.25/PRNewswire/-- FromNovember16-18,Phonak,the...esentedthesecondeditionoftheHearingCareforAdultsCo...tion.Theconferencebroughttogetherleadingexpertsina...inicianswhoworkeverydaywitholderpeoplewithhearingl...latestresearchandtrendsinhearingcareforolderpeople...
(Date:11/25/2009)...ewswire/--TheFDAgrantedtraditionalapprovalforINTEL...setranscriptaseinhibitor(NNRTI).INTELENCEistheonly...encedadultswhoareexperiencingvirologicfailurewithH...l(ARV)agents.Thetraditionalapprovalisbasedon48-wee...TELENCEiscurrentlymarketedintheU.S.byTibotecTherap...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 1Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 1Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 3Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3
...one Systems Incorporated,(Nasdaq: IMCL ) and Bris...nced,that the U.S. Food and Drug Administration (F...ximab) product labeling to include overall surviva...r inhibitor,(EGFR)-expressing metastatic colorecta...notecan- and oxaliplatin-based regimens. The appr...
...cond Cerimon Product Candidate to Enter Clinical ...SAN FRANCISCO, Oct. 2 Cerimon Pharmaceuticals,Inc...ical study of a novel,diclofenac sodium patch, the...e safety, tolerability, and systemic pharmacokinet...odium, a non-steroidal anti-inflammatory,drug (NSA...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 2Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 3
Liquichek D-dimer Control
... use in assessing compliance with specimen handlin...f custody, for Federal Workplace Drug Testing Prog...ealth Services Administration (SAMHSA), Health and... agencies. These samples are confirmed negative fo...
Liquichek Reticulocyte Stain
Seroconversion and Antigen Panel Chart
Medicine Products: